Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WR279396 with Occlusion for Old World Cutaneous Leishmaniasis
NCT01536795Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WR 279,396 in Old World cutaneous leishmaniasis (OWCL), sponsored by U.S. Army Medical Research and Development Command. Started Oct 2005; status: completed.
02
Drugs
WR 279,396
03
Conditions
Old World cutaneous leishmaniasis (OWCL)
Beyond the preview
Go deeper on NCT01536795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536795.